Search Results

You are looking at 221 - 230 of 957 items for :

  • "NCCN Clinical Practice Guidelines in Oncology NCCN Guidelines" x
  • Refine by Access: All x
Clear All
Full access

guidelines in collaboration with the NCCN. A set of 10 NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): China Editions are now available online at NCCNChina.org , enabling NCCN information to improve the effectiveness of treatment for a

Full access

is vital to oncology pharmacists in need of reliable, up-to-date, and evidence-based educational programs based on the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). NCCN has long recognized the importance of the oncology

Full access

innovative research that contributes significantly to understanding, diagnosing, and treating cancer. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines), developed by volunteer experts from the NCCN Member Institutions, are the recognized

Full access

Staff

attending the conference, its greatest value is the opportunity to hear about the latest updates to some of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) directly from the experts who helped create them. In fact, this year’s updates

Full access

Nicola Fossati, Alessandro Larcher, Alberto Briganti, and Firas Abdollah

Guidelines in Oncology (NCCN Guidelines) for Prostate Cancer 3 : low risk (PSA level <10 ng/mL, clinical stage ≤T2a, and biopsy Gleason score ≤6); high risk (PSA level >20 ng/mL, and/or clinical stage ≥T3, and/or biopsy Gleason score ≥8); or intermediate risk

Full access

comments about the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™), articles published in the journal, and about any topic relating to cancer prevention, detection, treatment, supportive care, or survivorship. Please send correspondence to

Full access

Robert W. Carlson

-known alliance of 13 academic cancer centers to a high-visibility, leading alliance of 26 major academic cancer centers. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) began as 10 and have grown to 61. The NCCN Guidelines are the most widely

Full access

Harold J. Burstein

Permissiveness is a common feature in most treatment guidelines, including the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). In general, if several treatment options are thought to be reasonable choices, they are all included

Full access

Al B. Benson III

After its 10-year anniversary, NCCN had emerged after a decade of experience enriched by an expanding, exquisite staff, a sense of mission, and a growing number of products radiating from the core NCCN Clinical Practice Guidelines in Oncology

Full access

Jeffrey Crawford

past decade, the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) have provided the most frequent updates and revisions for the clinical practitioner to help integrate evidence for use with the realities of clinical practice. For example